Suppr超能文献

孟加拉国确诊的血液系统恶性肿瘤——对10家专科医院5000多例病例的回顾性分析

Diagnosed hematological malignancies in Bangladesh - a retrospective analysis of over 5000 cases from 10 specialized hospitals.

作者信息

Hossain Mohammad Sorowar, Iqbal Mohd S, Khan Mohiuddin Ahmed, Rabbani Mohammad Golam, Khatun Hazera, Munira Sirajam, Miah M Morshed Zaman, Kabir Amin Lutful, Islam Naima, Dipta Tashmim Farhana, Rahman Farzana, Mottalib Abdul, Afrose Salma, Ara Tasneem, Biswas Akhil Ranjan, Rahman Mizanur, Abedin Akm Mustafa, Rahman Mahbubur, Yunus A B M, Niessen Louis W, Sultana Tanvira Afroze

机构信息

BRAC University, Mohakhali, Dhaka, Bangladesh.

出版信息

BMC Cancer. 2014 Jun 14;14:438. doi: 10.1186/1471-2407-14-438.

Abstract

BACKGROUND

The global burden from cancer is rising, especially as low-income countries like Bangladesh observe rapid aging. So far, there are no comprehensive descriptions reporting diagnosed cancer group that include hematological malignancies in Bangladesh.

METHODS

This was a multi-center hospital-based retrospective descriptive study of over 5000 confirmed hematological cancer cases in between January 2008 to December 2012. Morphological typing was carried out using the "French American British" classification system.

RESULTS

A total of 5013 patients aged between 2 to 90 years had been diagnosed with malignant hematological disorders. A 69.2% were males (n=3468) and 30.8% females (n=1545), with a male to female ratio of 2.2:1. The overall median age at diagnosis was 42 years. Acute myeloid leukemia was most frequent (28.3%) with a median age of 35 years, followed by chronic myeloid leukemia with 18.2% (median age 40 years), non-Hodgkin lymphoma (16.9%; median age 48 years), acute lymphoblastic leukemia (14.1%; median age 27 years), multiple myeloma (10.5%; median age 55 years), myelodysplastic syndromes (4.5%; median age 57 years) and Hodgkin's lymphoma (3.9%; median age 36 years). The least common was chronic lymphocytic leukemia (3.7%; median age 60 years). Below the age of 20 years, acute lymphoblastic leukemia was predominant (37.3%), followed by acute myeloid leukemia (34%). Chronic lymphocytic leukemia and multiple myeloma had mostly occurred among older patients, aged 50-over.

CONCLUSIONS

For the first time, our study presents the pattern and distribution of diagnosed hematological cancers in Bangladesh. It shows differences in population distributions as compared to other settings with possibly a lower presence of non-Hodgkin lymphoma. There might be under-reporting of affected women. Further studies are necessary on the epidemiology, genetics and potential environmental risk factors within this rapidly aging country.

摘要

背景

癌症的全球负担正在上升,尤其是像孟加拉国这样的低收入国家正经历快速老龄化。到目前为止,尚无全面描述孟加拉国确诊癌症群体(包括血液系统恶性肿瘤)的报告。

方法

这是一项基于多中心医院的回顾性描述性研究,研究对象为2008年1月至2012年12月期间确诊的5000多例血液系统癌症病例。采用“法国-美国-英国”分类系统进行形态学分型。

结果

共有5013例年龄在2至90岁之间的患者被诊断为恶性血液系统疾病。其中男性占69.2%(n = 3468),女性占30.8%(n = 1545),男女比例为2.2:1。诊断时的总体中位年龄为42岁。急性髓系白血病最为常见(28.3%),中位年龄为35岁,其次是慢性髓系白血病,占18.2%(中位年龄40岁),非霍奇金淋巴瘤(16.9%;中位年龄48岁),急性淋巴细胞白血病(14.1%;中位年龄27岁),多发性骨髓瘤(10.5%;中位年龄55岁),骨髓增生异常综合征(4.5%;中位年龄57岁)和霍奇金淋巴瘤(3.9%;中位年龄36岁)。最不常见的是慢性淋巴细胞白血病(3.7%;中位年龄60岁)。20岁以下,急性淋巴细胞白血病占主导(37.3%),其次是急性髓系白血病(34%)。慢性淋巴细胞白血病和多发性骨髓瘤大多发生在50岁以上的老年患者中。

结论

我们的研究首次呈现了孟加拉国确诊血液系统癌症的模式和分布。与其他地区相比显示出人群分布的差异,非霍奇金淋巴瘤的发病率可能较低。可能存在受影响女性报告不足的情况。在这个快速老龄化的国家,有必要对流行病学、遗传学和潜在环境风险因素进行进一步研究。

相似文献

3
Pattern of hematological malignancies in adolescents and young adults in Bangladesh.
Cancer Epidemiol. 2017 Dec;51:109-112. doi: 10.1016/j.canep.2017.11.001. Epub 2017 Nov 6.
7
[Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
Rev Epidemiol Sante Publique. 2009 Jun;57(3):151-8. doi: 10.1016/j.respe.2009.02.204. Epub 2009 Apr 17.
8
Spectrum of hematological malignancies and peripheral cytopenias.
J Nepal Health Res Counc. 2013 Sep;11(25):273-8.

引用本文的文献

1
Prognostic implications of MUC1 and XBP1 concordant expression in multiple myeloma: A retrospective study.
PLoS One. 2025 Apr 3;20(4):e0320934. doi: 10.1371/journal.pone.0320934. eCollection 2025.
2
Prevalence of hematological malignancies in Africa: A systematic review and meta-analysis.
Sci Rep. 2025 Mar 19;15(1):9471. doi: 10.1038/s41598-025-94428-w.
5
Autologous stem cell transplant program in 2016-country report from Bangladesh.
Blood Cell Ther. 2020 Feb 25;3(1):1-5. doi: 10.31547/bct-2019-006.
6
Hematologic malignancies of primary bone marrow involvement: a decade's experience in Bahrain.
Hematol Transfus Cell Ther. 2023 Jul;45 Suppl 2(Suppl 2):S68-S75. doi: 10.1016/j.htct.2022.02.002. Epub 2022 Mar 11.
9
Evaluation of plasma Epstein-Barr virus DNA as a biomarker for Epstein-Barr virus-associated Hodgkin lymphoma.
SAGE Open Med. 2021 Oct 29;9:20503121211054991. doi: 10.1177/20503121211054991. eCollection 2021.
10
Multiple myeloma in Armenia during the period 2006-2018: facts and discussion.
BMC Cancer. 2021 Aug 21;21(1):941. doi: 10.1186/s12885-021-08676-w.

本文引用的文献

1
Bangladesh: innovating for health.
Lancet. 2013 Nov 23;382(9906):1681-2. doi: 10.1016/S0140-6736(13)62294-1. Epub 2013 Nov 21.
2
Cancer control in Bangladesh.
Jpn J Clin Oncol. 2013 Dec;43(12):1159-69. doi: 10.1093/jjco/hyt140. Epub 2013 Oct 25.
5
Statistics of hematologic malignancies in Korea: incidence, prevalence and survival rates from 1999 to 2008.
Korean J Hematol. 2012 Mar;47(1):28-38. doi: 10.5045/kjh.2012.47.1.28. Epub 2012 Mar 28.
6
Assessment of 285 cases of chronic lymphocytic leukemia seen at single large tertiary center in Northern India.
Leuk Lymphoma. 2012 Oct;53(10):1961-5. doi: 10.3109/10428194.2012.672734. Epub 2012 May 21.
7
Meeting the challenge of hematologic malignancies in sub-Saharan Africa.
Blood. 2012 May 31;119(22):5078-87. doi: 10.1182/blood-2012-02-387092. Epub 2012 Mar 28.
9
Improving outcomes from breast cancer in a low-income country: lessons from bangladesh.
Int J Breast Cancer. 2012;2012:423562. doi: 10.1155/2012/423562. Epub 2011 Dec 5.
10
Lymphoid malignancies in U.S. Asians: incidence rate differences by birthplace and acculturation.
Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1064-77. doi: 10.1158/1055-9965.EPI-11-0038. Epub 2011 Apr 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验